Watchlist Manager

Watchlist

Price: 5.99 CNY -3.85% Market Closed

Market Cap: ¥7.8B

	NanJing Pharmaceutical Co Ltd SSE:600713	CN

Income Statement

Currency: CNY

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	42	0	0	0	54	0	0	0	61	0	0	0	86	0	0	0	128	0	0	0	126	0	0	0	176	0	0	0	306	0	0	0	329	0	0	0	262	0	0	0	306	0	0	0	232	0	0	0	214	0	0	74	295	243	317	344	320	317	341	366	392	385	370	327	370	309	322	344	439	377	354	341	333	331	354	363	522	368	353	349	494	300	0	0	0
Revenue	5 260 N/A	5 551 +6%	5 756 +4%	6 182 +7%	6 230 +1%	6 434 +3%	6 536 +2%	6 678 +2%	6 859 +3%	7 292 +6%	8 146 +12%	8 498 +4%	9 345 +10%	10 002 +7%	10 318 +3%	10 777 +4%	11 396 +6%	11 491 +1%	12 168 +6%	12 862 +6%	14 127 +10%	15 029 +6%	15 653 +4%	16 236 +4%	15 338 -6%	15 723 +3%	15 766 +0%	16 370 +4%	17 172 +5%	17 523 +2%	17 945 +2%	18 152 +1%	18 024 -1%	18 224 +1%	18 424 +1%	18 655 +1%	19 236 +3%	19 828 +3%	20 505 +3%	21 311 +4%	22 076 +4%	22 720 +3%	23 327 +3%	24 010 +3%	24 813 +3%	25 490 +3%	25 786 +1%	26 156 +1%	26 721 +2%	26 831 +0%	27 253 +2%	27 453 +1%	28 810 +5%	29 885 +4%	30 473 +2%	31 608 +4%	31 303 -1%	32 936 +5%	34 716 +5%	36 399 +5%	37 156 +2%	37 209 +0%	37 514 +1%	38 538 +3%	39 817 +3%	42 113 +6%	43 442 +3%	44 140 +2%	45 123 +2%	45 739 +1%	47 167 +3%	49 163 +4%	50 222 +2%	52 603 +5%	53 624 +2%	53 332 -1%	53 590 +0%	53 460 0%	53 479 +0%	53 981 +1%	53 696 -1%	53 991 +1%	54 431 +1%	53 893 -1%	54 963 +2%
Gross Profit
Cost of Revenue	(4 838)	(5 116)	(5 317)	(5 734)	(5 786)	(5 975)	(6 064)	(6 198)	(6 365)	(6 780)	(7 583)	(7 883)	(8 668)	(9 276)	(9 540)	(9 972)	(10 580)	(10 658)	(11 323)	(12 002)	(13 226)	(14 083)	(14 676)	(15 213)	(14 274)	(14 616)	(14 629)	(15 178)	(15 989)	(16 353)	(16 760)	(16 958)	(16 688)	(16 905)	(17 125)	(17 371)	(18 015)	(18 597)	(19 239)	(20 011)	(20 742)	(21 369)	(21 960)	(22 624)	(23 350)	(24 039)	(24 298)	(24 645)	(25 152)	(25 270)	(25 641)	(25 793)	(26 958)	(27 999)	(28 528)	(29 614)	(29 235)	(30 820)	(32 480)	(34 041)	(34 699)	(34 849)	(35 127)	(36 055)	(37 297)	(39 529)	(40 781)	(41 433)	(42 190)	(42 819)	(44 171)	(46 135)	(46 969)	(49 378)	(50 391)	(50 076)	(50 283)	(50 233)	(50 241)	(50 727)	(50 341)	(50 728)	(51 203)	(50 715)	(51 597)
Gross Profit	422 N/A	434 +3%	438 +1%	447 +2%	444 -1%	459 +3%	472 +3%	480 +2%	494 +3%	512 +4%	563 +10%	615 +9%	677 +10%	727 +7%	779 +7%	806 +3%	816 +1%	833 +2%	845 +1%	860 +2%	901 +5%	947 +5%	978 +3%	1 024 +5%	1 063 +4%	1 107 +4%	1 137 +3%	1 192 +5%	1 183 -1%	1 171 -1%	1 186 +1%	1 195 +1%	1 336 +12%	1 319 -1%	1 300 -1%	1 285 -1%	1 221 -5%	1 232 +1%	1 266 +3%	1 300 +3%	1 334 +3%	1 350 +1%	1 366 +1%	1 385 +1%	1 463 +6%	1 451 -1%	1 488 +3%	1 512 +2%	1 568 +4%	1 562 0%	1 613 +3%	1 661 +3%	1 853 +12%	1 887 +2%	1 947 +3%	1 995 +2%	2 068 +4%	2 117 +2%	2 237 +6%	2 359 +5%	2 457 +4%	2 361 -4%	2 387 +1%	2 483 +4%	2 520 +1%	2 584 +3%	2 661 +3%	2 707 +2%	2 934 +8%	2 920 0%	2 997 +3%	3 027 +1%	3 252 +7%	3 225 -1%	3 232 +0%	3 256 +1%	3 307 +2%	3 228 -2%	3 238 +0%	3 254 +1%	3 355 +3%	3 262 -3%	3 228 -1%	3 179 -2%	3 366 +6%
Operating Income
Operating Expenses	(377)	(386)	(389)	(396)	(388)	(397)	(408)	(412)	(427)	(446)	(471)	(519)	(551)	(596)	(634)	(646)	(672)	(684)	(705)	(720)	(741)	(767)	(786)	(832)	(934)	(945)	(967)	(996)	(1 186)	(1 148)	(1 166)	(1 190)	(1 072)	(1 189)	(1 123)	(1 078)	(906)	(891)	(930)	(933)	(932)	(912)	(916)	(909)	(983)	(975)	(1 001)	(1 019)	(1 011)	(958)	(978)	(993)	(1 214)	(1 233)	(1 225)	(1 272)	(1 309)	(1 274)	(1 350)	(1 415)	(1 513)	(1 398)	(1 392)	(1 433)	(1 508)	(1 448)	(1 471)	(1 462)	(1 634)	(1 556)	(1 598)	(1 639)	(1 971)	(1 771)	(1 752)	(1 762)	(1 798)	(1 684)	(1 695)	(1 705)	(1 859)	(1 733)	(1 772)	(1 786)	(2 068)
Selling, General & Administrative	(389)	(400)	(407)	(415)	(405)	(410)	(415)	(415)	(428)	(447)	(468)	(522)	(545)	(589)	(623)	(631)	(666)	(679)	(700)	(721)	(729)	(762)	(783)	(826)	(859)	(900)	(928)	(952)	(1 069)	(1 055)	(1 076)	(1 094)	(989)	(1 035)	(990)	(949)	(812)	(882)	(892)	(892)	(838)	(876)	(881)	(874)	(864)	(926)	(951)	(974)	(901)	(950)	(952)	(967)	(1 110)	(1 166)	(1 193)	(1 230)	(1 149)	(1 282)	(1 330)	(1 407)	(1 316)	(1 377)	(1 392)	(1 439)	(1 329)	(1 451)	(1 468)	(1 453)	(1 461)	(1 544)	(1 585)	(1 622)	(1 605)	(1 764)	(1 755)	(1 763)	(1 513)	(1 679)	(1 676)	(1 691)	(1 560)	(1 720)	(1 757)	(1 769)	(1 763)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(2)	(1)	(6)	(8)	(5)	(11)	(11)	(12)	(7)	(16)	(15)	(14)	(8)	(17)	(19)	(23)	(12)	(21)	(24)	(26)	(18)	(31)	(32)	(34)	(27)	(38)	(41)	(38)	(24)	(30)	(27)	(26)	(46)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(70)	0	0	0	(87)	0	0	0	(89)	0	0	0	(105)	0	0	0	(94)	0	0	0	(106)	0	0	0	(122)	0	0	0	(140)	0	0	0	(151)	0	0	0	(156)	0	0	0	(264)	0	0	0	(275)	0	0	0	(270)	0	0	0	(255)
Other Operating Expenses	12	15	19	21	17	14	7	3	1	2	(2)	3	(6)	(8)	(11)	(15)	(6)	(6)	(7)	(1)	(11)	(7)	(3)	(6)	(76)	(45)	(40)	(45)	(118)	(92)	(88)	(94)	(14)	(152)	(133)	(130)	(7)	(9)	(39)	(41)	(5)	(35)	(36)	(36)	(15)	(50)	(49)	(44)	(14)	(10)	(27)	(27)	4	(64)	(27)	(35)	(33)	19	(8)	5	(51)	(6)	13	18	(19)	20	16	14	(4)	9	11	10	(84)	24	34	35	17	33	22	24	(4)	17	13	9	(4)
Operating Income	45 N/A	48 +7%	49 +2%	52 +6%	56 +8%	63 +13%	65 +3%	69 +6%	67 -3%	68 +1%	94 +38%	97 +3%	126 +30%	130 +3%	144 +11%	160 +11%	144 -10%	150 +4%	141 -6%	140 -1%	161 +15%	179 +11%	191 +7%	191 N/A	129 -32%	162 +26%	170 +5%	196 +15%	(3) N/A	22 N/A	19 -14%	3 -84%	264 +8 700%	129 -51%	175 +36%	206 +18%	315 +53%	340 +8%	336 -1%	366 +9%	401 +10%	437 +9%	449 +3%	476 +6%	480 +1%	476 -1%	487 +2%	492 +1%	558 +13%	601 +8%	632 +5%	665 +5%	638 -4%	653 +2%	720 +10%	722 +0%	759 +5%	841 +11%	886 +5%	942 +6%	944 +0%	962 +2%	994 +3%	1 049 +6%	1 012 -4%	1 135 +12%	1 189 +5%	1 245 +5%	1 300 +4%	1 364 +5%	1 398 +3%	1 389 -1%	1 281 -8%	1 454 +13%	1 480 +2%	1 494 +1%	1 509 +1%	1 543 +2%	1 543 0%	1 549 +0%	1 496 -3%	1 529 +2%	1 456 -5%	1 392 -4%	1 298 -7%
Pre-Tax Income
Interest Income Expense	(28)	(32)	(40)	(35)	(26)	(51)	(48)	(54)	(48)	(48)	(49)	(34)	(30)	(28)	(47)	(72)	(92)	(98)	(88)	(84)	(101)	(115)	(130)	(131)	(141)	(180)	(200)	(230)	(159)	(211)	(230)	(157)	(260)	(151)	(145)	(217)	(219)	(214)	(223)	(244)	(279)	(198)	(173)	(159)	(204)	(213)	(216)	(213)	(212)	(233)	(251)	(269)	(283)	(312)	(328)	(339)	(313)	(367)	(390)	(420)	(417)	(500)	(514)	(501)	(402)	(440)	(460)	(494)	(521)	(544)	(529)	(507)	(371)	(486)	(493)	(511)	(504)	(531)	(531)	(531)	(477)	(497)	(479)	(458)	(423)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(44)	0	0	0	19	0	0	0	58	0	0	0	(17)	0	0	0	1	0	28	28	58	89	61	94	34	34	34	17	2	71	71	56	66	14	17	16	67	77	74	79	24	6	6	1	2	7	6	7	4	3	9	9	285
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	22	0	0	0	15	0	0	0	(1)	0	0	0	(2)	0	0	0	22	0	(1)	0	16	0	(1)	(1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	0	0	0	(0)
Total Other Income	4	7	6	0	7	24	24	25	16	20	19	15	27	25	30	27	10	11	9	11	13	34	35	33	33	49	52	54	14	13	6	2	100	117	117	120	(9)	0	(2)	1	8	19	18	9	12	13	16	18	(7)	(10)	(12)	(6)	(8)	(21)	(21)	(24)	(4)	(2)	(3)	67	61	57	57	(15)	2	2	3	7	(7)	(10)	(16)	(23)	(28)	(30)	(27)	(29)	(29)	(24)	(20)	(16)	(20)	(17)	3	6	(2)
Pre-Tax Income	21 N/A	22 +5%	13 -41%	17 +31%	37 +118%	36 -3%	41 +14%	40 -2%	35 -13%	39 +11%	62 +59%	78 +26%	123 +58%	126 +2%	127 +1%	116 -9%	65 -44%	64 -2%	63 -2%	68 +8%	94 +38%	98 +4%	96 -2%	93 -3%	36 -61%	30 -17%	22 -27%	21 -5%	(150) N/A	(174) -16%	(205) -18%	(152) +26%	58 N/A	96 +66%	149 +55%	109 -27%	129 +18%	124 -4%	108 -13%	121 +12%	204 +69%	257 +26%	294 +14%	326 +11%	271 -17%	277 +2%	288 +4%	298 +3%	340 +14%	360 +6%	399 +11%	420 +5%	405 -4%	408 +1%	430 +5%	451 +5%	476 +6%	506 +6%	528 +4%	608 +15%	589 -3%	591 +0%	609 +3%	589 -3%	678 +15%	711 +5%	749 +5%	773 +3%	839 +8%	887 +6%	927 +5%	937 +1%	906 -3%	944 +4%	966 +2%	956 -1%	978 +2%	995 +2%	997 +0%	1 008 +1%	1 003 -1%	1 018 +1%	989 -3%	949 -4%	1 158 +22%
Net Income
Tax Provision	(10)	(10)	(7)	(6)	(9)	(9)	(10)	(10)	(12)	(12)	(24)	(27)	(52)	(54)	(48)	(46)	(20)	(22)	(19)	(20)	(39)	(38)	(43)	(49)	(42)	(46)	(54)	(61)	(33)	(38)	(35)	(30)	(63)	(63)	(68)	(75)	(63)	(58)	(46)	(35)	(52)	(61)	(73)	(86)	(78)	(80)	(86)	(87)	(101)	(108)	(124)	(128)	(120)	(124)	(115)	(130)	(130)	(135)	(143)	(152)	(157)	(161)	(174)	(173)	(208)	(213)	(221)	(226)	(228)	(240)	(195)	(195)	(190)	(196)	(264)	(263)	(265)	(269)	(263)	(265)	(260)	(256)	(264)	(240)	(325)
Income from Continuing Operations	12	11	5	11	27	29	33	30	23	26	38	53	71	75	81	71	44	41	42	46	55	59	53	44	(6)	(15)	(31)	(40)	(183)	(213)	(241)	(183)	(5)	31	79	33	65	66	62	86	152	195	220	239	193	196	201	210	239	251	275	293	284	285	315	320	346	370	384	455	432	430	435	417	470	499	529	547	611	646	732	743	716	748	702	693	713	726	735	744	743	762	725	709	833
Income to Minority Interest	(13)	(12)	(10)	(11)	(12)	(13)	(15)	(13)	(12)	(14)	(16)	(20)	(25)	(25)	(26)	(19)	(14)	(11)	(10)	(14)	(6)	(10)	(8)	(5)	16	20	16	18	1	1	5	0	16	6	0	(1)	(27)	(22)	(17)	(21)	(24)	(29)	(36)	(39)	(36)	(38)	(44)	(47)	(58)	(61)	(64)	(67)	(52)	(46)	(55)	(62)	(82)	(98)	(98)	(94)	(85)	(78)	(75)	(82)	(94)	(97)	(103)	(107)	(105)	(111)	(116)	(114)	(120)	(135)	(130)	(128)	(135)	(138)	(154)	(164)	(172)	(173)	(175)	(178)	(208)
Equity Earnings Affiliates	4	0	2	2	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	2 N/A	2 N/A	(3) N/A	2 N/A	18 +800%	18 N/A	20 +11%	20 N/A	11 -45%	14 +27%	24 +71%	34 +42%	47 +38%	50 +6%	55 +10%	52 -5%	30 -42%	30 N/A	33 +10%	33 N/A	49 +48%	50 +2%	45 -10%	39 -13%	9 -77%	4 -56%	(16) N/A	(23) -44%	(183) -696%	(212) -16%	(236) -11%	(183) +22%	11 N/A	39 +255%	81 +108%	34 -58%	39 +15%	43 +10%	44 +2%	64 +45%	129 +102%	166 +29%	183 +10%	199 +9%	157 -21%	158 +1%	158 N/A	164 +4%	180 +10%	190 +6%	210 +11%	224 +7%	232 +4%	237 +2%	259 +9%	258 0%	264 +2%	273 +3%	287 +5%	362 +26%	347 -4%	352 +1%	361 +3%	336 -7%	376 +12%	403 +7%	426 +6%	440 +3%	505 +15%	536 +6%	616 +15%	629 +2%	596 -5%	612 +3%	571 -7%	566 -1%	578 +2%	588 +2%	581 -1%	579 0%	571 -2%	589 +3%	551 -7%	531 -4%	625 +18%
EPS (Diluted)	0 N/A	0 N/A	-0.01 N/A	0 N/A	0.03 N/A	0.03 N/A	0.04 +33%	0.04 N/A	0.02 -50%	0.03 +50%	0.04 +33%	0.05 +25%	0.08 +60%	0.08 N/A	0.09 +12%	0.09 N/A	0.05 -44%	0.05 N/A	0.05 N/A	0.05 N/A	0.08 +60%	0.08 N/A	0.07 -12%	0.06 -14%	0.01 -83%	0.01 N/A	-0.02 N/A	-0.03 -50%	-0.26 -767%	-0.31 -19%	-0.34 -10%	-0.27 +21%	0.02 N/A	0.05 +150%	0.11 +120%	0.05 -55%	0.06 +20%	0.06 N/A	0.06 N/A	0.09 +50%	0.14 +56%	0.2 +43%	0.22 +10%	0.23 +5%	0.17 -26%	0.19 +12%	0.19 N/A	0.19 N/A	0.2 +5%	0.22 +10%	0.24 +9%	0.26 +8%	0.26 N/A	0.23 -12%	0.28 +22%	0.24 -14%	0.26 +8%	0.28 +8%	0.28 N/A	0.35 +25%	0.33 -6%	0.33 N/A	0.34 +3%	0.32 -6%	0.36 +12%	0.39 +8%	0.42 +8%	0.42 N/A	0.49 +17%	0.45 -8%	0.51 +13%	0.47 -8%	0.48 +2%	0.48 N/A	0.44 -8%	0.44 N/A	0.45 +2%	0.45 N/A	0.45 N/A	0.44 -2%	0.44 N/A	0.45 +2%	0.34 -24%	0.39 +15%	0.43 +10%

Income Statement Balance Sheet Cash Flow Statement

NanJing Pharmaceutical Co Ltd
SSE:600713

Income Statement

Earnings Waterfall
NanJing Pharmaceutical Co Ltd

Income Statement
NanJing Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

NanJing Pharmaceutical Co Ltd SSE:600713

Income Statement

Earnings Waterfall NanJing Pharmaceutical Co Ltd

Income Statement NanJing Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

NanJing Pharmaceutical Co Ltd
SSE:600713

Earnings Waterfall
NanJing Pharmaceutical Co Ltd

Income Statement
NanJing Pharmaceutical Co Ltd